Nick Halper is the co-founder of Braingrade, a neuromodulation company pursuing a therapy for Alzheimer’s Disease and eventually general cognitive enhancement.
Nick is a cellular neuroscientist that transitioned into invasive neurotechnologies when he moved to Blackrock Microsystems as an engineer. Through his time at Blackrock, Nick filled roles in engineering, quality, regulatory and marketing before settling into product management at business strategy. In this role, Nick helped diversify the revenue sources of the company, focusing on contract engineering and new medical devices.
Within this business strategy role, Nick helped consult several academic groups from the lab bench into their first clinical trials. He is excited to help guide Braingrade to the same goal.